Profil
Aljanae Reynolds is currently working as a Media Contact at Rapt Therapeutics, Inc. He previously worked as a Media Contact at Aduro BioTech, Inc.
Aktive Positionen von Aljanae Reynolds
| Unternehmen | Position | Beginn |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Public Communications Contact | - |
Ehemalige bekannte Positionen von Aljanae Reynolds
| Unternehmen | Position | Ende |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RAPT THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
